Navigation Links
Compendia Bioscience Announces the Release of Oncomine 4 Research Edition
Date:9/23/2009

l and cancer samples
  • Meta COPA, adding this analysis to the Oncomine interface for quick results
  • Concepts Map integration, allowing smooth workflows

    • While improved user experience was the driving force in Oncomine 4 Research Edition, the entire Oncomine database was scrutinized in an effort to standardize and catalog all data points. In creating the Compendia Ontology, 300,000+ sample facts across 30,000+ samples were individually reviewed and terms normalized.

    About Compendia Bioscience, Inc.

    Compendia Bioscience is dedicated to harnessing the global collection of high throughput molecular data to provide researchers with the data and analysis tools necessary to validate biomarker and gene target discoveries, better understand mechanisms of disease, and optimize clinical outcomes. www.compendiabio.com

    About Oncomine(TM)

    Oncomine combines a rapidly growing compendium of 39,000+ expertly curated cancer genomic profiles with a sophisticated analysis engine and a powerful web application for data mining and visualization. Oncomine facilitates target discovery and validation and supports the prioritization of tumor populations for drug development. http://www.compendiabio.com/products/products.htm


    '/>"/>
    SOURCE Compendia Bioscience, Inc.
    Copyright©2009 PR Newswire.
    All rights reserved

    0

    GOOD

    Page: 1 2

    Related biology technology :

    1. Compendia Bioscience Announces the Receipt of a $2.4M SBIR Award and Related Management Changes
    2. Compendia Bioscience Announces the Release and Availability of Oncomine(TM) Research Premium Edition
    3. GlaxoSmithKline Signs Licensing Agreement With Compendia Bioscience
    4. On Third Anniversary, Compendia Bioscience Announces Continued Revenue Growth, Major Long-Term Customer Contracts and Forecasts Profitability
    5. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
    6. Selection of Development Candidate Triggers $0.5 Million Milestone Payment to Ardea Biosciences, Inc.
    7. ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook
    8. Ohio Ranks Best in the Midwest for Venture Capital Investment in Health Care Bioscience Industry
    9. ONCOSCIENCE AG, THE EUROPEAN PARTNER OF YM BIOSCIENCES, ANNOUNCES COMPLETION OF PATIENT ENROLLMENT IN PHASE III BRAIN CANCER TRIAL OF NIMOTUZUMAB
    10. Pressure BioSciences, Inc. Reports Second Quarter 2007 Financial Results and Provides Business Update
    11. YM BIOSCIENCES, EUROPEAN PARTNER, ONCOSCIENCE AG, ANNOUNCES INITIATION OF ADVANCED NIMOTUZUMAB TRIALS IN ADULT GLIOMA AND PANCREATIC CANCER
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/17/2013)... IAC Industries wants to share with you the ... to set up and furnish a research lab knowing that ... a year’s time. How does a company make choices in ... What is efficient and cost-effective? , The solution was ... The planners at DisperSol determined that the concept of modular ...
    (Date:5/16/2013)... (PRWEB) May 16, 2013 In late 2012, ... to speak to doctors in China about Appearance Medicine ... NZ, this was her first trip to lecture in China, ... visited Guangzhou and Fuzhou, home to 12 and 7 million ... is very high at this point in time. As Dr. ...
    (Date:5/16/2013)... 2013  The registration deadline has been extended until ... 2013 National Conference, the premier conference for bioscience financial ... the Hilton San Diego Bayfront. "We ... and want to make sure as many people as ... Brandi Roberts , Chief Financial Officer of Mast ...
    (Date:5/16/2013)... , May 16, 2013 ... research report is available in its ... Cardiac Biomarkers for Acute Coronary Syndromes ... http://www.reportlinker.com/p01182969/MediPoint-Diagnostic-Cardiac-Biomarkers-for-Acute-Coronary-Syndromes---APAC-Analysis-and-Market-Forecasts.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic ... Acute Coronary Syndromes - APAC Analysis ...
    Breaking Biology Technology:New Downloadable Success Story: “How To Outfit a Dynamic Lab in Flux” 2Registration Extended Until May 22 for Association of Bioscience Financial Officers (ABFO) 2013 National Conference -- San Diego 2Registration Extended Until May 22 for Association of Bioscience Financial Officers (ABFO) 2013 National Conference -- San Diego 3Registration Extended Until May 22 for Association of Bioscience Financial Officers (ABFO) 2013 National Conference -- San Diego 4MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 2MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 3MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 4MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 5MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 6MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 7MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 8
    ... N.J., Jan. 3 Pharmos Corporation,(Nasdaq: PARS ... initial closing of,a private placement of its 10% ... the Company issued $4,000,000 principal amount of the,Debentures, ... same amount., The purchasers consisted of certain ...
    ... RUTHERFORD, N.J., Jan. 3 Cambrex,Corporation (NYSE: ... A. Mack,Chairman, President and Chief Executive Officer, will ... Healthcare Conference on January 8, 2008 at,9:00 a.m. ... California., (Logo: http://www.newscom.com/cgi-bin/prnh/20000613/CAMBREXLOGO ), ...
    ... Holdings, Inc., a fully,integrated critical care biopharmaceutical company, ... will present at the 26th Annual JPMorgan,Healthcare Conference ... PST. The,conference will be held January 7-10 at ... About Ikaria Holdings, Inc., Ikaria Holdings, Inc. ...
    Cached Biology Technology:Pharmos Corporation Completes Initial Closing of Private Placement 2
    (Date:5/16/2013)... May 16, 2013 Integrated Biometrics patented ... a custom thin film transistor camera introduces Sherlock, ... roll image in the smallest and lightest form ... Appendix F Mobile ID FAP 45, Certified scanner ... in size and weight when compared to optical ...
    (Date:5/16/2013)... from Canada and around the world are meeting ... Neuroscience Meeting will showcase the latest in research ... reveal clues to understanding the disorders that affect ... and this meeting will showcase the best of ... says Sam David, President of the Canadian Association ...
    (Date:5/15/2013)... its benefit in moderating gout risk, new research reveals ... reduce uric acid (urate) levels to a clinically significant ... alone or in combination with allopurinol, appears to have ... gout patients according to the results published in the ... Rheumatism . , Gout is an inflammatory arthritis ...
    Breaking Biology News(10 mins):7th Annual Canadian Neuroscience Meeting, Toronto, May 20-24, 2013 2Vitamin C does not lower uric acid levels in gout patients 2
    ... In a paper available at the online site of ... of UCLA researchers reports for the first time that ... stimulating production of the antimicrobial protein cathelicidin. The ... active form of vitamin D, leading to production of ...
    ... basic molecules that make up all living things have ... people are right- or left-handed. This chirality has a ... living organisms. The inception of chirality from the elementary ... mysteries of the origin of life. Scientists at ...
    ... granted to start the first safety and tolerability trial ... an incurable, paralyzing neurodegenerative disorder that strikes 5 persons ... in the most active period of their lives − ... previously shown the possibilities for the use of VEGF ...
    Cached Biology News:Argonne scientists discover possible mechanism for creating 'handedness' in biological molecules 2First trial in patients with a potential treatment of the incurable ALS muscle disease 2First trial in patients with a potential treatment of the incurable ALS muscle disease 3
    ... The Chemicon Detergent-OUT SDS Kit is a ... from protein solutions. Removes detergents without ... load the protein solution on the Detergent-OUT ... solution. Med columns are suitable for ...
    ... from Paraffin embedded tissue blocks, which are ... ensure the highest quality. Tissues of each ... sectioned at a thickness of 5 microns ... large (3-5 mm in diameter) in comparison ...
    ... Zyagen tissue microarrays are derived from Paraffin ... rigorous quality control procedures to ensure the ... manually assembled in one block, sectioned at ... on coated slides. Sections are large (3-5mm ...
    ... Precision-designed for Optimal Microdissection , CapSure HS ... precise and rapid extraction of populations of ... samples with Laser Capture Microdissection., Ensure ... Molecular Analysis , All CapSure LCM Caps ...
    Biology Products: